Trial intelligence / Profile preview

Sanghe Jianghuo Granules in Girls With Precocious Puberty

NCT07637019Not yet recruiting

Sponsor
Children's Hospital of Fudan University
Start
Jul 2026
Primary completion
Mar 2028
Countries
1
01

Overview

Randomised, double-blind trial in precocious puberty comparing Sanghe Jianghuo Granules with Placebo (2 arms). Primary endpoint: Breast Nodule Regression Rate at 12 weeks. Planned start Jul 2026; status: not yet recruiting.

02

Drugs

Sanghe Jianghuo Granules
03

Conditions

precocious puberty

Beyond the preview

Go deeper on NCT07637019.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07637019.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call